During the regular meetings, the Board reviewed a number of matters, including: committee reports; reports from the CEO (including environmental, health and safety, markets, and competition) and from the CFO and the Group’s General Counsel; review and approval of the Form 20-F filing with the SEC; approval of the agenda items for the annual General Meeting of shareholders; approval of executive remuneration; reports from business units; review of Company strategy; R&D review; review of 2021 budget; finance reports; presentation on investor perception, and Board and Committee's self-evaluation results.